Patent · US Active

Compositions for improving the quality of the meibum composition of inflamed or dysfunctional meibomian glands

US9115078B2 · kind B2 · utility

7Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 18, 2012
Grant dateAug 25, 2015
Priority date
Expiry dateAug 19, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/593
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to methods for administering an effective amount of a dietary or nutritional supplement composition that effectively changes the quality of the meibum lipid composition of inflamed or dysfunctional meibomian glands so as to improve or increase tear break up time, reduce tear osmolarity, and elevate the omega-3 index, while reducing or eliminating the symptoms associated with dry eye or meibomianitis. The dietary or nutritional supplement composition administered to the patient suffering from inflamed or dysfunctional meibomian glands comprises an effective amount of omega-3 fatty acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.